loadpatents
name:-0.016433954238892
name:-0.0073120594024658
name:-0.0030028820037842
Cummings; Maxwell David Patent Filings

Cummings; Maxwell David

Patent Applications and Registrations

Patent applications and USPTO patent grants for Cummings; Maxwell David.The latest application filed is for "pyrazole derivatives as malt1 inhibitors".

Company Profile
4.9.15
  • Cummings; Maxwell David - Ambler PA
  • Cummings; Maxwell David - Strafford PA
  • Cummings; Maxwell David - Wayne PA
  • Cummings; Maxwell David - Stratford PA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Pyrazole derivatives as MALT1 inhibitors
Grant 11,040,031 - Lu , et al. June 22, 2
2021-06-22
Pyrazole derivatives as MALT1 inhibitors
Grant 10,954,214 - Lu , et al. March 23, 2
2021-03-23
Pyrazole derivatives as MALT1 inhibitors
Grant 10,888,550 - Lu , et al. January 12, 2
2021-01-12
Pyrazole Derivatives As Malt1 Inhibitors
App 20190381019 - Lu; Tianbao ;   et al.
2019-12-19
Pyrazole Derivatives As Malt1 Inhibitors
App 20190381012 - LU; Tianbao ;   et al.
2019-12-19
Pyrazole Derivatives As Malt1 Inhibitors
App 20180170909 - Lu; Tianbao ;   et al.
2018-06-21
Thiophene sulfoximines, compositions thereof, and methods of treating complement-mediated diseases and conditions
Grant 7,868,023 - Subasinghe , et al. January 11, 2
2011-01-11
Novel Thiophene Sulfoximines, Compositions Thereof, And Methods Of Treating Complement-mediated Diseases And Conditions
App 20080255108 - Subasinghe; Nalin L. ;   et al.
2008-10-16
Protease inhibitors
Grant 7,405,209 - Marquis, Jr. , et al. July 29, 2
2008-07-29
Thiophene sulfoximines, compositions thereof, and methods of treating complement-mediated diseases and conditions
Grant 7,385,066 - Subasinghe , et al. June 10, 2
2008-06-10
Novel thiophene sulfoximines, compositions thereof, and methods treating complement-mediated diseases and conditions
App 20070066667 - Subasinghe; Nalin L. ;   et al.
2007-03-22
Substituted 1,4-diazepines and uses thereof
App 20060235007 - Lu; Tianbao ;   et al.
2006-10-19
Substituted 1,4-diazepines and uses thereof
Grant 7,115,598 - Lu , et al. October 3, 2
2006-10-03
Peptide deformylase inhibitors
Grant 7,115,605 - Aubart , et al. October 3, 2
2006-10-03
Protease inhibitors
App 20050256104 - Marquis, Robert Wells JR. ;   et al.
2005-11-17
Substituted 1,4-diazepines and uses thereof
App 20040220179 - Lu, Tianbao ;   et al.
2004-11-04
Peptide deformylase inhibitors
Grant 6,806,369 - Aubart , et al. October 19, 2
2004-10-19
Peptide deformylase inhibitors
App 20040192719 - Aubart, Kelly M. ;   et al.
2004-09-30
Peptide deformylase inhibtors
App 20040053932 - Aubart, Kelly M. ;   et al.
2004-03-18
Peptide deformylase inhibitors
App 20040034024 - Aubart, Kelly M ;   et al.
2004-02-19
Protease inhibitors
App 20040002487 - Marquis, Robert Wells JR. ;   et al.
2004-01-01
Protease inhibitors
App 20030225061 - Marquis, Robert Wells JR. ;   et al.
2003-12-04
Protease inhibitors
App 20030144175 - Marquis, Robert Wells JR. ;   et al.
2003-07-31
Protease inhibitors
App 20020147188 - Marquis, Robert Wells JR. ;   et al.
2002-10-10

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed